Cardiocell LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://stemcardiocell.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
Phase 2
Completed
- Conditions
- Non-Ischemic Heart Failure
- Interventions
- Drug: Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)Drug: Lactated Ringer's Solution
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- CardioCell LLC
- Target Recruit Count
- 23
- Registration Number
- NCT02467387
- Locations
- 🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States
News
No news found